Immunohistochemistry may also direct the diagnosis, such as loss of FH-staining in HLRCC-associated RCC and loss of SDHA or SDHB staining in SDH-deficient RCC in the context of SDH deficiency syndrome. This evidence concerns the gene SDHA and renal cell adenocarcinoma.